CompletedNot applicableNCT04618783

Cross-neutralization Capacity of Immune Serum From Different Dosage of Sabin Inactivated Poliovirus Vaccine Immunization

Studying Poliomyelitis

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Sinovac Biotech Co., Ltd
Principal Investigator
Yuemei Hu, Bachelor
Jiangsu Provincial Center for Disease Control and Prevention
Intervention
Three doses of low-dosage investigational sIPV, vaccinated within one-month interval between doses(biological)
Enrollment
250 target
Eligibility
All sexes
Timeline
2019 – 2020

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04618783 on ClinicalTrials.gov

Other trials for Poliomyelitis

Additional recruiting or active studies for the same condition.

See all trials for Poliomyelitis →

← Back to all trials